In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Ideaya Biosciences Inc (NASDAQ: IDYA) was $17.44 for the day, down -3.16% from the previous closing price of $18.01. In other words, the price has decreased by -$3.16 from its previous closing price. On the day, 0.77 million shares were traded. IDYA stock price reached its highest trading level at $18.04 during the session, while it also had its lowest trading level at $17.05.
Ratios:
Our analysis of IDYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.97 and its Current Ratio is at 14.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $51.
On November 05, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $27.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 24, 2024, with a $50 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 1526652288 and an Enterprise Value of 869504128. For the stock, the TTM Price-to-Sale (P/S) ratio is 218.09 while its Price-to-Book (P/B) ratio in mrq is 1.42. Its current Enterprise Value per Revenue stands at 124.215 whereas that against EBITDA is -2.679.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.44, which has changed by -0.5841607 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $44.42, while it has fallen to a 52-week low of $16.95. The 50-Day Moving Average of the stock is -17.22%, while the 200-Day Moving Average is calculated to be -42.08%.
Shares Statistics:
IDYA traded an average of 881.89K shares per day over the past three months and 956380 shares per day over the past ten days. A total of 86.50M shares are outstanding, with a floating share count of 80.84M. Insiders hold about 7.65% of the company’s shares, while institutions hold 101.01% stake in the company. Shares short for IDYA as of 1741910400 were 9884508 with a Short Ratio of 11.21, compared to 1739491200 on 8898446. Therefore, it implies a Short% of Shares Outstanding of 9884508 and a Short% of Float of 12.57.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
